Literature DB >> 17569626

Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

Kenneth W Hance1, Connie J Rogers, Stephen D Hursting, John W Greiner.   

Abstract

A number of lifestyle factors that reduce cancer risk in the primary prevention setting may be potential new targets for use in combination with cancer vaccines. This review discusses the modulation of energy balance (physical activity, calorie restriction, and obesity prevention), and the supplementation with natural and synthetic analogs of vitamins A and E, as potential interventions for use in combination with cancer vaccines. Additionally, the pharmacologic manipulation of nutrient metabolism in the tumor microenvironment (e.g., arachidonic acid, arginine, tryptophan, and glucose metabolism) is discussed. This review includes a brief overview of the role of each agent in primary cancer prevention; outlines the effects of these agents on immune function, specifically adaptive and/or anti-tumor immune mechanisms, when known; and discusses the potential use of these interventions in combination with therapeutic cancer vaccines. Modulation of energy balance through exercise and strategies targeting nutrient metabolism in the tumor microenvironment represent the most promising interventions to partner with therapeutic cancer vaccines. Additionally, the use of vitamin E succinate and the retinoid X receptor-directed rexinoids in combination with cancer vaccines offer promise. In summary, a number of energy balance- and nutrition-related interventions are viable candidates for further study in combination with cancer vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569626      PMCID: PMC2844938          DOI: 10.2741/2444

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  346 in total

1.  Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.

Authors:  T G O'Brien; L C Megosh; G Gilliard; A P Soler
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

2.  Delayed reduction in T cell precursor frequencies accompanies diet-induced lifespan extension.

Authors:  R A Miller; D E Harrison
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.

Authors:  Kazuhiko Yanagisawa; Mark A Exley; Xiaofeng Jiang; Nobuhiro Ohkochi; Masaru Taniguchi; Ken-ichiro Seino
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

Review 4.  Metabolic mechanisms of tumor resistance to T cell effector function.

Authors:  Candace M Cham; Thomas F Gajewski
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

Authors:  M A Anzano; C W Peer; J M Smith; L T Mullen; M W Shrader; D L Logsdon; C L Driver; C C Brown; A B Roberts; M B Sporn
Journal:  J Natl Cancer Inst       Date:  1996-01-17       Impact factor: 13.506

6.  Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects.

Authors:  S N Meydani; M P Barklund; S Liu; M Meydani; R A Miller; J G Cannon; F D Morrow; R Rocklin; J B Blumberg
Journal:  Am J Clin Nutr       Date:  1990-09       Impact factor: 7.045

7.  T lymphopenia in genetically obese rats.

Authors:  S i Tanaka; F Isoda; T Yamakawa; M Ishihara; H Sekihara
Journal:  Clin Immunol Immunopathol       Date:  1998-02

8.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

9.  Mitogenic response of T-lymphocytes to exercise training and stress.

Authors:  G D Tharp; T L Preuss
Journal:  J Appl Physiol (1985)       Date:  1991-06

10.  The influence of physical activity in 1,2 dimethylhydrazine induced colon carcinogenesis in the rat.

Authors:  G Andrianopoulos; R L Nelson; C T Bombeck; G Souza
Journal:  Anticancer Res       Date:  1987 Jul-Aug       Impact factor: 2.480

View more
  6 in total

1.  Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice.

Authors:  Connie J Rogers; David Berrigan; David A Zaharoff; Kenneth W Hance; Arti C Patel; Susan N Perkins; Jeffrey Schlom; John W Greiner; Stephen D Hursting
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

2.  Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study.

Authors:  Yani Lu; Jennifer Prescott; Jane Sullivan-Halley; Katherine D Henderson; Huiyan Ma; Ellen T Chang; Christina A Clarke; Pamela L Horn-Ross; Giske Ursin; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2009-10-12       Impact factor: 4.897

Review 3.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease.

Authors:  Ana García-Lafuente; Eva Guillamón; Ana Villares; Mauricio A Rostagno; José Alfredo Martínez
Journal:  Inflamm Res       Date:  2009-04-21       Impact factor: 4.575

4.  Exercise enhances vaccine-induced antigen-specific T cell responses.

Authors:  Connie J Rogers; David A Zaharoff; Kenneth W Hance; Susan N Perkins; Stephen D Hursting; Jeffrey Schlom; John W Greiner
Journal:  Vaccine       Date:  2008-08-14       Impact factor: 3.641

Review 5.  Effects of obesity on immune responses to renal tumors.

Authors:  Vincent Chehval; Lyse A Norian
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

6.  In vitro Production of IL-6 and IFN-γ is Influenced by Dietary Variables and Predicts Upper Respiratory Tract Infection Incidence and Severity Respectively in Young Adults.

Authors:  Huicui Meng; Yujin Lee; Zhaoyong Ba; Jennifer A Fleming; Emily J Furumoto; Robert F Roberts; Penny M Kris-Etherton; Connie J Rogers
Journal:  Front Immunol       Date:  2015-03-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.